Enhancing Lung Cancer Therapy with Nutrient Supplementation

通过营养补充增强肺癌治疗

• 批准号: 428905
• 负责人: Klassen Pamela
• 金额: $ 1.27万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-12-01 至 2020-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=428905&lang=en
• 关键词: Chemotherapy; Disease Control Rate; Docosahexaenoic Acid; Eicosapentaenoic Acid; Fatty Acid; Immunotherapy; Myosteatosis; Omega-3; Skeletal Muscle Mass

"Over 29,000 Canadians will receive a devastating diagnosis of lung cancer in 2019; the majority with non-small cell lung cancer (NSCLC). Most often diagnosed at an incurable stage, NSCLC is treated with chemotherapy and immunotherapy to slow tumor growth

“2019年将有超过29，000名加拿大人接受肺癌的毁灭性诊断;大多数患有非小细胞肺癌（NSCLC）。NSCLC通常在无法治愈的阶段被诊断出来，通过化疗和免疫疗法来减缓肿瘤生长